Using XAV939 as the prototype small molecule tankyrase inhibitor, we demonstrated that pharmacological inhibition of TNKS1 achieved similar effects as TNKS1 knockdown in HCC cell lines. The gene discussed is TNKS; the disease is hepatocellular carcinoma.